Title here

Text here
 
Donate Now

Multidisciplinary Association For Psychedelic Studies Organization Name provided in the GuideStar Exchange* as of 05/14/2014: Multidisciplinary Association For Psychedelic Studies

Organization Name as listed in the IRS Business Master File as of 08/11/2014: MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

AKA  MAPS
Santa Cruz, CA
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

GuideStar Summary

&1002;                GuideStar Exchange Committed to transparency ?
This organization is a Gold-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your nonprofit? Update your information today!
&1002; Registered with IRS Legitimacy information is available
&1002; Financial Data Annual Revenue and Expense data reported
&1002; Forms 990 2013, 2012, and 2011 Forms 990 filed with the IRS
&1002; Mission Objectives Mission Statement is available
&1002; Impact Summary Impact Summary from the nonprofit and Charting Impact Report are available
  5 stars Average rating from 656 Personal Reviews | Write a Review

Basic Organization Information

Multidisciplinary Association For Psychedelic Studies Organization Name provided in the GuideStar Exchange* as of 05/14/2014: Multidisciplinary Association For Psychedelic Studies

Organization Name as listed in the IRS Business Master File as of 08/11/2014: MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
Also Known As: MAPS
Physical Address: Santa Cruz, CA 95060 
EIN: 59-2751953
Web URL: www.maps.org 
NTEE Category: H Medical Research
H99 Other Medical Research N.E.C.
F Mental Health, Crisis Intervention
F30 Mental Health Treatment
R Civil Rights, Social Action, Advocacy
R05 Research Institutes and/or Public Policy Analysis
Year Founded: 1986 
Ruling Year: 1986 
How This Organization Is Funded: Board Member 1 - $200,000
Board Member 2 - $130,000
Individual - $402,160


Sign in or create an account to see this organization's full address, contact information, and more!

Mission Statement

MAPS' mission is to develop psychedelics and marijuana into prescription medicines; educate therapists in psychedelic therapy; build a network of clinics where treatments can be provided; and to educate the public honestly about the risks and benefits of these substances.

Legitimacy Information

This organization is registered with the IRS.

This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Annual Revenue & Expenses (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Fiscal Year Starting: June 1, 2012
Fiscal Year Ending: May 31, 2013

Total Revenue $2,134,160
Total Expenses $2,094,291

Revenue & Expenses (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Fiscal Year Starting: June 1, 2012
Fiscal Year Ending: May 31, 2013

Sign in or create an account to view this information from the GuideStar Exchange

The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Chart Illustration Revenue and Expense data from Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »

Balance Sheet (IRS Form 990)

Chart Illustration Balance Sheet data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Forms 990 Received from the IRS Additional Information
IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar website is an ongoing process.

Sign in or create an account to view Form(s) 990 for 2013, 2012, 2011.

Chart Illustration Forms 990 for 2013, 2012, 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Forms 990 Provided by the Nonprofit

Financial Statements

Chart Illustration Financial Statements for 2013, 2012 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Annual Reports

Sign in or create an account to view this information.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Leadership (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Rick Doblin, Ph.D.

Profile:

MAPS Founder and Executive Director Rick Doblin received a Ph.D. in Public Policy in 2001 from Harvard's Kennedy School of Government, where he also obtained a Master's in Public Policy in 1990. His dissertation was on the regulation of the medical use of psychedelics and marijuana, and is posted on the MAPS website. Rick has studied with Dr. Stan Grof, and was in the first group to become certified as Holotropic Breathwork practitioners. He has published several papers, including a follow-up study to Walter Pahnke's Good Friday experiment and Timothy Leary's Concord Prison experiment.

Leadership Statement:

It has taken work across several generations, and will likely require several generations more, to realize the mission of the Multidisciplinary Association for Psychedelic Studies (MAPS), which I founded in 1986. However, we are making great progress on achieving our goals. We have seven studies of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) initiated or in the final stages of the approval process. We are sponsoring Phase 2 pilot studies in South Carolina, Colorado, Canada, and Israel, along with a Phase 1 psychotherapist training protocol, and a Phase 2 Relapse Study. We anticipate holding our crucial End-of-Phase 2 meeting with the FDA at the end of 2015. In this meeting we will plan our pivotal multi-site Phase 3 studies designed to gather proof of safety and efficacy required for prescription approval for MDMA-assisted psychotherapy for PTSD. MAPS continues to receive positive coverage of its work in major media outlets, and reaches thousands of people through its website, Bulletin, and MAPS published books and events. In April 2013, MAPS hosted its third international psychedelic research conference, which drew 1,900 attendees from 33 countries, attracted major media attention and provided a place for researchers to share their most recent findings with each other and the general public. Our psychedelic harm reduction program has provided volunteer training and services for individuals having difficult experiences in Portugal, Central America, South Africa and the US, in the last year alone. The momentum is building. We have an incredible amount of work to do, but with the help of the international community we are closer than ever to accomplishing our goals and helping create a world where psychedelics are safely and legally available for beneficial use, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Board Chair (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Sign in or create an account to view this information from the GuideStar Exchange

Board of Directors (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Sign in or create an account to view this information from the GuideStar Exchange

Officers for Fiscal Year (IRS Form 990)

Chart Illustration Report Added To Cart Officers for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now

Highest Paid Employees & Their Compensation (IRS Form 990)

Highest Paid Employee data is not available for this organization.

People information was last updated by the nonprofit in May 2014

Click here if you are associated with this organization and want to provide updated information.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Programs

Program: MDMA-assisted Psychotherapy Drug Development Plan (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Budget:
$19,000,000
Category:
Pharmaceuticals
Population Served:
General Public/Unspecified
Military/Veterans
None

Program Description:

MDMA-assisted psychotherapy is an innovative treatment that combines psychotherapy with the administration of MDMA, an off-patent pharmacological adjunct. MDMA (3,4-methylenedioxymethamphetamine) is widely recognized for its ability to decrease fear and defensiveness while increasing trust and empathy. MDMA opens a “window of tolerance” in patients undergoing psychotherapy for PTSD—and holds it open long enough for them to step through. MDMA makes it easier for patients to be comfortable between the extremes of fear and avoidance, and increases the effectiveness of psychotherapy by strengthening the alliance between therapist and patient. MDMA promotes the release of oxytocin and prolactin, hormones associated with trust and bonding, helping patients discuss their painful memories openly and honestly. In MAPS’ initial US Phase 2 pilot study, 83% of the subjects receiving MDMA-assisted psychotherapy no longer met the criteria for PTSD, after suffering from treatment-resistant PTSD for an average of over 19 years. These results were published in the July 2010 issue of the Journal of Psychopharmacology. A long-term follow-up study conducted an average of 3½ years after the first study revealed that, on average, these benefits were sustained. These results were published in the November 2012 issue of the Journal of Psychopharmacology. Our MDMA-assisted psychotherapy drug development plan includes Phase 2 clinical studies currently underway in Boulder, CO, Charleston, SC, Beer Yaakov, Israel, and a study in the start up phase in Vancouver, Canada. MAPS’ MDMA-assisted psychotherapy drug development plan estimates expenses of about $3 million over the next three years to complete our international series of Phase 2 pilot studies. We estimate that roughly $16 million over the following seven years will be needed to complete Phase 3 and obtain FDA approval for the prescription use of MDMA-assisted psychotherapy for PTSD. Phase 3 expense estimates will become clearer after our End-of-Phase 2 meeting with FDA, the purpose of which is to determine the design of the Phase 3 studies. We are actively looking for individuals and institutions that are interested in investing in developing MDMA-assisted psychotherapy into a treatment for PTSD sufferers. We are fortunate to have a temporarily restricted fund of $5 million for our Phase 3 studies, currently invested at the San Francisco Foundation, and we have been successful in raising the funds needed to date for Phase 2. We are challenged yet confident about our ability to raise funds for the remaining study costs.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Institutional Review Boards, U.S. Food and Drug Administration, Drug Enforcement Agency, Health Canada, Israeli Ministry of Health, Internal monitoring team, Independent Raters, and Medical Monitor

Program Success Examples:

Program: Marijuana in 70 Veterans with Chronic Treatment-Resistant PTSD (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Budget:
$885,000
Category:
Pharmaceuticals
Population Served:
Military/Veterans
None
None

Program Description:

In this randomized, placebo-controlled, double-blind crossover pilot study, marijuana will be tested as a pharmacological agent to manage PTSD symptoms in 70 veterans with chronic, treatment-resistant post traumatic stress disorder (PTSD).This will be the first controlled clinical trial testing this specific therapeutic potential of marijuana and will investigate the premise that using marijuana eases the symptoms of PTSD with a sufficiently favorable risk profile. Two drug-delivery methods, smoking and vaporizing, will be examined with four marijuana strains each with a different level of D9-tetrahydrocannabinol (THC, 0.0 %, 2 %, 6 %, 12 %) along with a fifth strain containing equal potencies of THC and cannabidiol (CBD, 6% THC, 6% CBD). During Stage 1, 70 outpatient subjects will self-administer up to 1.8 grams of one of five different potencies of marijuana daily for four weeks, followed by a two week period of medication washout. Subjects will be given a one week supply of marijuana at a time, saving any unused marijuana each day in the original packaging for return to the study staff for weighing prior to receiving the next week’s supply. Stage 2 will be a randomized, blinded, crossover involving another 4-week period of marijuana use followed by 2 weeks of cessation. There will be an optional Stage 3 extension that will assess participants who request to consume the remaining marijuana that they previously returned. Assessments of PTSD and depression symptoms will be conducted prior, during and after after cessation of use. The Principal Investigator is Dr. Suzanne Sisley, M.D. Assistant Professor, Internal Medicine/Psychiatry, The University of Arizona College of Medicine-Phoenix, Scottsdale AZ. Dr. Michael Mithoefer is the Medical Monitor. Dr. Mithoefer has designed and implemented four FDA-approved clinical trials administering MDMA-assisted psychotherapy for the treatment of PTSD, and has served as medical monitor for seven clinical trials. He is currently the PI in clinical study of the safety and efficacy of MDMA-assisted psychotherapy for veterans and firefighters with PTSD. We estimate that the study will begin in July 2014, once final approval has been received from the DEA and marijuana has been received from NIDA. The study takes 15 months for each participant, with the follow-up visit occurring 12 months after the end of the last visit. Assuming that ten participants can be enrolled each month, the study should take approximately 29 months to complete. In the first year of the study, start-up activities will be completed and the first 20 subjects will be enrolled. In the second year, the remaining 50 subjects will be enrolled. Data collection and analysis will be completed in the third year.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

Program: Public Education (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Budget:
--
Category:
Communications & Public Education
Population Served:
Adults
None
None

Program Description:

MAPS produces a number of educational projects, including publishing the tri-annual MAPS Bulletin, sharing a monthly email newsletter, publishing books relevant to our mission, maintaining educational websites such as mdmaptsd.org and mdma-autism.org, engaging with diverse audiences through social media, offering webinars, and more. In fiscal year 2013, for example, MAPS educational publications and advocacy included publishing three editions of the Maps Bulletin; developing and managing three websites about psychedelic research; producing and distributing 12 monthly email newsletters; implementing media and public relations campaigns with international television, radio, print, and online journalists and press organizations; and publishing two new books: a revised edition of Claudio Naranjo’s “The Healing Journey, and the first English translation of Torsten Passie’s “Healing With Entactogens. Educational events included the Psychedelic Science 2013 conference, our largest non-research activity, held in April 2013. Over 1,900 people attended the conference and associated events over the five-day event in Oakland, Calif., which presented over 100 speakers from more than 30 countries. In addition, MAPS staff attended more than 18 events organized by others; secured speakers for those and other events; managed exhibit booths and art galleries; sold books and maps Bulletins; and distributed free clinical protocols and peer-reviewed Journal articles.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

Program: Zendo Harm Reduction Project (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
May 2014)

Budget:
$30,000
Category:
Communications & Public Education
Population Served:
Adults
None
None

Program Description:

Through the Zendo Project, MAPS offers an onsite harm reduction service that provides tranquil space and compassionate care for individuals having difficult psychedelic experiences. The Zendo Project: • Provides a supportive space for individuals undergoing difficult psychedelic experiences or other psychological challenges in order to turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations; • Creates an environment where volunteers can work alongside one another to improve their harm reduction skills and receive training and feedback; • Demonstrates that safe, productive psychedelic experiences are possible without the need for law enforcement-based policies. Each year Zendo Project services are offered at about a half-dozen Festivals internationally. In 2013, services were offered in: Envision Festival In Uvita, Costa Rica; 70th Anniversary Bicycle Day Party, San Francisco, California; Burning Man, Black Rock City, Nevada; and Afrikaburn, Tankwa, South Africa

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Impact Summary from the Nonprofit Additional Information
A Charting Impact Report consists of an organization’s responses to the five questions. Helping validate this self-reported data are three reviews. Once an organization has used the online interface to complete its report, its responses will produce a document with a unique URL that will be shared on this website, on your GuideStar profile, on the reports of charities participating in BBB Wise Giving Alliance evaluations, and – in the future – with other websites and information sources about nonprofits. We encourage organizations to use this URL to share their report on their own website and through their own media channels. Participants will receive guidance about promoting their Charting Impact Report, along with other benefits, once they publish their report.

MAPS primary project is to investigate MDMA-assisted psychotherapy as a novel treatment for PTSD in clinical trials conducted under U.S. FDA regulations. Our goal is to ease the suffering of many thousands of people worldwide who have experienced psychological trauma.
For more in-depth information about this organization's impact, view their Charting Impact Report.
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Reviews

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Contractor data is available for this organization!

Independent Contractor information for 2012, 2011, 2010 is available for this organization with a subscription to GuideStar Premium Pro.

GuideStar Premium Pro also includes:

  • Comprehensive financial data, including functional expense detail, for every digitized fiscal year in GuideStar's database
  • Ability to download up to 55 fields of data for up to 1,000 organizations at a time and up to five years’ worth of Income Statement and Balance Sheet data for individual organizations
  • Comprehensive advanced search capabilities, including criteria for functional expenses, investible assets, investment income and audit & 990T filing requirements
  • Ability to save organizations and searches for quick reference
  • People search with salary range data
  • Access to all available Forms 990

More information

Upgrade Now!

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium